newsfilter
← Latest News
GlobeNewswire·

Aravive Announces Fast Track Designation of Batiraxcept for Treatment of ccRCC

HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the U.S. Food